# PTC Therapeutics, Inc.: Form 8-K, filed Jun 16, 2026

- Company: [PTC Therapeutics, Inc.](/companies/ptct.md) (CIK 1070081)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 07:00 ET
- Period: 2026-06-15
- Accession: 0001104659-26-074292
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070081/000110465926074292/tm2618041d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070081/000110465926074292/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070081/000110465926074292/tm2618041d1_8k.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-074292. Last ingested by Listed: Nov 3, 2026, 09:26 ET. No prices; not investment advice.